The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hypercholesterolemia
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 19 years and 125 years
- Gender
- Both males and females
Description
Following subjects with AMI event within 1 month will be assessed MACE event for 1year Essential hypertension or heart failure Idiopathic hypercholesterolemia (heterogeneous familial and non-familial hypercholesterolemia, Fredrickson classification type IIa) Mixed-type hypercholesterolemia (Fredrick...
Following subjects with AMI event within 1 month will be assessed MACE event for 1year Essential hypertension or heart failure Idiopathic hypercholesterolemia (heterogeneous familial and non-familial hypercholesterolemia, Fredrickson classification type IIa) Mixed-type hypercholesterolemia (Fredrickson classification type IIb) with acute myocardial infarction (STEMI, NSTEMI),
Tracking Information
- NCT #
- NCT04270344
- Collaborators
- Not Provided
- Investigators
- Study Chair: Myungho Jeong, Professor Chonnam National University Hospital
Get Well Soon